GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (XSWX:COLOB) » Definitions » Cyclically Adjusted Price-to-FCF

Coloplast A/S (XSWX:COLOB) Cyclically Adjusted Price-to-FCF : (As of Sep. 27, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Coloplast A/S Cyclically Adjusted Price-to-FCF?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted Price-to-FCF for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Coloplast A/S Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Coloplast A/S's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S Cyclically Adjusted Price-to-FCF Chart

Coloplast A/S Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 65.24 72.94 68.89 46.43 44.66

Coloplast A/S Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51.70 44.66 45.24 58.68 52.49

Competitive Comparison of Coloplast A/S's Cyclically Adjusted Price-to-FCF

For the Medical Instruments & Supplies subindustry, Coloplast A/S's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast A/S's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast A/S's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Coloplast A/S's Cyclically Adjusted Price-to-FCF falls into.



Coloplast A/S Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Coloplast A/S's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, Coloplast A/S's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=0.691/118.5000*118.5000
=0.691

Current CPI (Jun. 2024) = 118.5000.

Coloplast A/S Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201409 0.762 99.700 0.906
201412 0.374 99.400 0.446
201503 0.030 100.200 0.035
201506 0.639 100.300 0.755
201509 0.836 100.200 0.989
201512 0.344 99.800 0.408
201603 0.249 100.200 0.294
201606 0.309 100.600 0.364
201609 0.736 100.200 0.870
201612 0.097 100.300 0.115
201703 0.104 101.200 0.122
201706 0.654 101.200 0.766
201709 0.955 101.800 1.112
201712 0.599 101.300 0.701
201803 0.207 101.700 0.241
201806 0.860 102.300 0.996
201809 1.017 102.400 1.177
201812 0.456 102.100 0.529
201903 0.227 102.900 0.261
201906 0.851 102.900 0.980
201909 1.060 102.900 1.221
201912 0.553 102.900 0.637
202003 0.239 103.300 0.274
202006 0.818 103.200 0.939
202009 0.983 103.500 1.125
202012 -0.012 103.400 -0.014
202103 0.362 104.300 0.411
202106 0.797 105.000 0.899
202109 1.142 105.800 1.279
202112 0.610 106.600 0.678
202203 -0.012 109.900 -0.013
202206 0.852 113.600 0.889
202209 1.060 116.400 1.079
202212 0.132 115.900 0.135
202303 0.250 117.300 0.253
202306 0.542 116.400 0.552
202309 0.908 117.400 0.917
202312 0.901 116.700 0.915
202403 -1.729 118.400 -1.730
202406 0.691 118.500 0.691

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Coloplast A/S  (XSWX:COLOB) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Coloplast A/S Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Coloplast A/S's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast A/S Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast AS is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S Headlines

No Headlines